Impact statements
-
In this study, a global advanced competency framework for the pharmacy workforce was developed through a four-staged multiple methods approach.
-
This framework is a pivotal step in advancing the pharmacy workforce.
-
In order to accelerate the advancement of the global workforce in all sectors and settings, transnational collaboration is encouraged.
-
An international glossary of terms on advanced and specialist practice is needed.
-
As part of framework implementation, it is recommended that a professional recognition system and an education and training programme be developed.
Introduction
Aim
Ethics approval
Method
Stage I: adoption of ALF: initial content and cultural validation
Stage II: transnational modified Delphi
Stage | Sample description |
---|---|
1. Initial content and cultural validation (n: five countries). | Two categories of countries: a. Countries with established advanced competency frameworks: Australia, Singapore and United Kingdom b. Countries with advanced competency framework drafts: Indonesia and Jordan |
2. Transnational modified Delphi peer reference group (n: 21 experts). | Twenty-one experts with the following countries and expertise: a. Country Algeria (1), Argentina (1), Australia (2), Canada (1), Croatia (1), Indonesia (1), Japan (1), Jordan (1), Nigeria (2), Portugal (1), Qatar (1), Sudan (1), Syria (1), Netherlands (3), United Kingdom (1), and United States (2) b. Expertise in* The competency development process (4), Education and training (6), Interprofessional collaboration (1), Leadership (8), Management (17), Policy and advocacy (2), Pharmacy practice and service development (4), Research and evaluation (13), and Scientific development (3) |
3. Transnational external engagement with the global pharmacy leadership community (n: 29 experts). | Twenty-nine responses were received from the following countries and broad affiliations: a. Country Algeria, Germany, Ghana (3), India, Indonesia, Kuwait, Malawi, New Zealand, Nigeria (2), Norway, Pakistan (3), Portugal, Rwanda, South Africa, Switzerland, United Arab Emirates, Zambia, Zimbabwe (2), and do not provide country information (5) b. Expertise Worked in university (n:10), practitioners (n:7), professional organisation (n:5), and affiliation not provided (n: 7) |
4. Case studies from countries at the individual (n: 7), institutional (n:2) and national (n: 5) levels. | a. Seven individual case studies from: Australia (a hospital pharmacist); Singapore (3 hospital pharmacists and a primary care pharmacist), and United Kingdom (2 hospital pharmacists) b. Two institutional case studies from Australia and United Kingdom (university setting) c. Five national case studies (Australia, Singapore, United Kingdom, Indonesia and Jordan) |
Stage III: transnational external engagement with the global pharmacy leadership community
Stage IV: collation of case studies from countries on framework implementation at the individual, institutional and national levels
Results
Sample description
Feedback about the framework
Part of the framework | Suggestions/modifications | Actions to the framework and relevant competency items |
---|---|---|
Cluster 1. Expert professional practice
| ||
Expert skills and knowledge | A missing gap related to prescribing practice | This feedback was not incorporated considering prescribing practice may not be available in all countries |
Patient care responsibilities | This competency may not be relevant to non-patient-facing role (e.g., academic, industry, regulatory, pharmaceutical sciences) | This competency: “patient care responsibilities” was modified to “developing professional expertise” |
Reasoning and judgement | It might be good to have some wording related to problem solving | “Problem-solving skills” was added to this competency item |
Cluster 2. Working with others
| ||
Communication | “Patients, colleagues and clinicians” seems to be only relevant for those working in patient care setting Consider adding a component of empowerment in communication skills Perhaps there is need to have a separate competency for “communication” with patients and other healthcare professionals | “Patients, colleagues and clinicians” was modified to “relevant stakeholders” An ability to “empower” was added to this competency item This feedback was not incorporated into the framework to provide a broader and flexible concept of global workforce advancement |
Teamwork and consultation | “Across boundaries” needs to be described further | “Across boundaries” was modified to “across boundaries (profession/sector/area)” |
Cluster 3. Leadership
| ||
Strategic context | The descriptor of advanced stage 3 at the “strategic context” competency item, which is to “create national healthcare policies”, might not apply to practitioners | This descriptor was modified to “demonstrate active participation in creating relevant local, national, regional or global policies.” This is because the focus of this competency item was about active participation in the policy creation, which could be done at the local, national, regional or global levels. |
Governance | “Clinical governance” was deemed challenging to translate in other languages. | “Clinical governance” was modified to “Standard, quality and accountability” |
Innovation | It is not clear what “requires limited supervision” means | “Required limited supervision” was modified to “often requires supervision for others” |
Cluster 4. Management
| ||
Managing change | The descriptors for advanced stage 3 of “managing change” should include the ability to promote, initiate and/or lead a process of change, not only to manage change | This descriptor was modified to “Demonstrates ability to promote, initiate and/or lead a process of change at a higher level” |
Strategic planning | The experts suggested further descriptions of the competency descriptor related to the “strategic planning” by considering countries’ political and economic instability | This descriptor was modified to include skills in “adapting the planning based on organisational politics changes in the internal and external environment” |
Cluster 5. Education, training and development
| ||
Conducting education and training | This competency is not only about conducting teaching effectively but also to deliver teaching and feedback effectively Perhaps this competency could refer to advanced degrees or credentials in the education part. | Conduct teaching efficiently was modified to “Deliver teaching and feedback effectively” This feedback was not incorporated into the framework to provide a broader and flexible concept of global workforce advancement |
Links practice and education | Involvement in the education and training in some countries is not only related to formal education but also in other ways | The stage 1 descriptor, which includes “formal education” was modified to “Participates in the delivery of education and training” |
Educational policy | Policy on workforce does not only include education, but also planning and development | “Workforce education” was modified to “workforce education, planning and development” |
Cluster 6. Research and evaluation
| ||
Develops and evaluates research protocols | There was no research structure in the clinical setting of this competency—so this competency may not be relevant in the country | This feedback was not incorporated into the framework because this competency was essential for advancing pharmacy practice |
Establishes research partnerships | The word “Specialist” in the competency descriptor provides a narrow context of competency | Remove “specialist” in the “specialist research” to provide a broader term to the description |
Any other comments
| ||
Stages in the framework -Advanced stage 1 -Advanced stage 2 -Advanced stage 3 | The application of the staging related to if this framework applies beyond a few years of pharmacists’ career (foundational stage) or if it applies from day 1 of their professional career. Also, how this framework relates to the current global competency framework for early career pharmacists | The staging levels are further described in the footnotes |
Feedback about framework dissemination and implementation
“Clinical governance is a term that widely western countries (or more focusing on UK system). I do not think non-English speaking countries would be able to understand this.” [Japan].
“Will the GADF be associated with recommendations for the development of formal career progression systems at country level, that are linked to competency assessment and certification (and that could eventually be linked to requirements for certain positions, or with remuneration scales, for example)?” [Netherlands].
“The basic concept should be translated into actual and up-to-date adapted global and local statements which from the strategic perspective translate into (national) actions and priorities with specific topics depending on regulatory and legal conditions for pharmacists working in the different pharmaceutical areas.” [Switzerland].
“I think it would be helpful to use this as a Member Organization (MO) benefit. I suggest that FIP develops some guidance documentation around how this Framework can be used.” [New Zealand].
“Let us build the Global framework of Global Pharmacy Training development and practice embracing individual national and regional towards global desired standards.” [Zambia].
“Advertising and marketing this to physicians and other healthcare professions. Cost-benefit evaluation to demonstrate all of this. [At the end] it’s the patient.” [United States].
Framework drivers, development, implementation and impact at the national and institutional levels
Utilisation, support needed and barriers in using the framework from individual perspectives
Category | Findings |
---|---|
Context of using the framework |
For personal growth and development
1. To track self-growth, progress and achievement over time; 2. To facilitate self-reflection in order to review where they are and to acquire skillsets for self-directed learning; 3. To focus on targeted areas for personal growth and development.
To map towards national standards and demonstrate impact for patient care
1. To work towards national pharmacy standards; 2. To collate evidence for detailing career and impact on patient care.
To link with scopes of practice and roles
1. To benchmark in taking specific ‘advanced’ practitioner roles; 2. To chart journey based on job scope. |
Use of the framework for professional and/or career development | 1. To develop a personal portfolio: Portfolio guides career development, track progress, and identifies areas for improvement. 2. To support the job application: By supporting the application to attain a consultant post. 3. To support other team members: Mentoring and guiding other pharmacists through the portfolio development process and mentoring them to identify their strengths and weaknesses for addressing their developmental gaps. 4. To provide evidence of advancement in the workplace: As a result of pharmacists being recognised as advanced practitioners, employers will have tangible evidence of their employees’ enhanced capability. 5. To attain specific job grades – linked with promotion: This framework has been mapped to the job grades. Each job grade must achieve a specific competency level in a specific area. 6. To develop targeted programmes for staff in the workplace: With the framework in place, workplace managers can identify common weaknesses among their employees and devise training programmes to address them. |
Additional tools and resources which could assist engagement with the framework |
Tools and templates to support the framework
1. Provide templates and examples of portfolios for practitioners on similar career paths. 2. Provide an online modifiable portfolio template where practitioners can build their portfolios and upload evidence in the system. 3. Provide a training roadmap to help practitioners identify the courses required to reach their desired performance level.
Organise workshops or courses related to: 1. Reflective writing; 2. Portfolio building and assessment; 3. How to gather effective evidence; 4. Peer review learning; 5. Providing feedback.
Provide support in mentoring and coaching
Provide support to set up mentors or coaches who can provide feedback and facilitate the development of practitioners; this could be organised in the workplace.
Other supports
1. Provide resources to allow and support pharmacists to protect their time in reflecting and writing up their portfolios. 2. Organise peer review sessions. 3. Engage with other professional organisations to foster collaboration in providing an impact on patient care. 4. Engage with the early career workforce to introduce them to the idea of an advanced practice framework at an early stage and help them incorporate it into their long-term career goals. 5. Promote the recognition and utilisation of the framework in the job roles. 6. Promote the use of the framework as part of re-validation processes for pharmacists. |
Barriers to utilising the framework |
Micro-level barriers - individual
1. The process of collecting evidence and building a portfolio is time-consuming and intensive. There is no time allotted for personal growth and advancement in individual job plans. 2. Lack of pharmacist’s motivation, where pharmacists may not see the immediate benefits of creating their portfolio as a value-add to their career development. 3. Questions on the value of this framework for senior practitioners remain related to what happens when a practitioner attains expert for all domains. 4. The unfamiliarity of the process of gathering evidence for portfolio and understanding the competency standards. 5. The ability to write reflectively varies greatly between individuals; this may affect practitioners’ integrity and morale.
Meso-level barriers – workplace
1. A flat organisational chart and lean staffing structure create difficulty for practitioners in collating evidence for advancement. 2. Limited link on how professional recognition system or credentialling provide additional benefits in the workforce or additional roles, responsibilities, or remuneration. 3. There are a limited number of vacancies for promotion even if practitioners have the necessary skills and experience to move up in the organisation.
Macro-level barriers -national
1. How to get buy-in from the whole workforce since the framework is not ‘mandated’; 2. How to implement the framework consistently throughout all the institutions within the nation; 3. Lack of specific performance indicators for assessing the framework’s effectiveness and impact; 4. Lack of education supervisors to support in mentoring and coaching. |